PRED FORTE
Generic Formulation: PREDNISOLONE ACETATE
Regulatory Registrant: Allergan, Inc.
Related NDC Products
| NDC Code | Dosage Form | Route | Category |
|---|---|---|---|
| 85401-021 | SUPPOSITORY | VAGINAL | UNAPPROVED HOMEOPATHIC |
| 54973-3257 | TABLET | ORAL | UNAPPROVED HOMEOPATHIC |
| 54973-3274 | TABLET | ORAL | UNAPPROVED HOMEOPATHIC |
| 43857-0151 | LIQUID | ORAL | UNAPPROVED HOMEOPATHIC |
| 43857-0166 | LIQUID | ORAL | UNAPPROVED HOMEOPATHIC |
Indications & Usage
INDICATIONS AND USAGE PRED FORTE ® is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.
Dosage & Administration
DOSAGE AND ADMINISTRATION Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely. If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS ).
Side Effects
ADVERSE REACTIONS The following adverse reactions have been identified during use of PRED FORTE ® . Because reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Adverse reactions include elevation of intraocular pressure (IOP) with possible development of glaucoma and infrequent optic nerve damage, posterior subcapsular cataract formation, and delayed wound healing. The development of secondary ocular infection (bacterial, fungal, and viral) has occurred. Fungal and viral infections of the cornea are particularly prone to develop coincidentally with long-term applications of steroids. The possibility of fungal invasion should be considered in any persistent corneal ulceration where steroid treatment has been used (see PRECAUTIONS ). Other adverse reactions reported with the use of prednisolone acetate ophthalmic suspension include: allergic reactions; dysgeusia; eye pain; foreign body sensation; headache; pruritus; rash; transient burning and stinging upon instillation and other minor symptoms of ocular irritation; urticaria; and visual disturbance (blurry vision). Keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids. Corticosteroid-containing preparations have also been reported to cause acute anterior uveitis and perforation of the globe.